Gene and Cell Therapy – News and Features

This strategic alliance leverages Tissue Genesis' cell isolation expertise and opens up a new market for its TGI 1000 platform cell isolation systems.

ThermoGenesis and UC Davis will develop stem cell therapies based upon ThermoGenesis' AutoXpress™, BioArchive® and CryoSeal® Fibrin Sealant blood processing systems.

University of Surrey researchers have received £100k grant to support work with the University of California, Irvine, researching the use of nanomaterials in stem cell growth.

Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group has acquired rights to patents relating to purifying nucleic acids.

The Consortium is aims at letting users of the Company’s products and solutions share their experience to speed development of gene therapy clinical trials.

Copernicus shows that the methods used to produce DNA nanoparticles were also very effective when applied to siRNA.

The grant provided by California Institute for Regenerative Medicine will be used to upgrade the current core facility and to support the establishment of a new satellite facility.

A study demonstrating therapeutic utilization of human stem cells, including application to X-SCID was presented at the 10th ASGT meeting.

Researchers have identified a population of stem cells in adult muscle that may one day be targeted to treat degenerative muscle diseases.

The Scripps Researchers will use the grant to develop treatment for patients who are losing their sight due to neovascular and retinal degenerative diseases.